Golden Helix ACMG 2024 User Meeting
Join us for an enlightening and engaging Golden Helix User Meeting at ACMG 2024, where we dive deep into the latest advancements and updates from Golden Helix. This is your chance to connect with fellow professionals, explore cutting-edge genetic analysis tools, and get firsthand insights into how our solutions are evolving to meet the future of genomic analysis. This is an opportunity to ask questions on the fly and engage directly with the Golden Helix team. Please note that there is limited availability for this event.
Date & Time: March 12th, 8:00 am - 11:30 pm
Location: Toronto Marriott City Centre Hotel, One Blue Jays Way, Toronto, ON M5V 1J4, Canada
Presented by:
Dr. Andreas Scherer, President and CEO
Darby Kammeraad, Director of Field Application Services
Nathan Fortier, Director of Research
Agenda
Start your day with networking over breakfast. A perfect opportunity to meet fellow NGS professionals and set the tone for a day of discovery.
A warm welcome and an overview of Golden Helix and what to expect throughout the user meeting.
Discover the latest updates with Golden Helix. From our recent receival of ISO 13485:2016 Certification, our partnership with PacBio, the latest updates to Golden Helix CancerKB database, and the launch of our new pharmacogenomics product, VSPGx.
Learn details on our latest product, VSPGx. This is our latest offering specifically for pharmacogenomics workflows.
With our new PacBio partnership, we are more adaptable than ever with creating a spectrum of custom workflows to suit our unique user needs. From gene panels to whole genome, from short to long-read sequencing, the VarSeq suite is the solution for NGS analysis and reporting in a modern clinical lab. VarSeq handles the spectrum of variant types (SNV, Indel, CNV, Fusions) and provides automated classification and reporting capabilities following the ACMG and AMP guidelines.
Enjoy a coffee, ask questions, network, and more.
We will present and discuss structural variants and advanced automation in VSClinical ACMG, VSWarehouse tracking changing variant evidence and classifications, and the exciting new developments that are coming to VarSeq, VSClinical, and VSWarehouse.
we will highlight how the combination of our new oncogenicity classifier and the updates to our CancerKB database streamline the interpretation of oncogenic variants. In addition, as NGS labs progress from gene panels to WES analysis for ideal genomic signature generation, we will demonstrate how a VarSeq somatic workflow can scale with these increased scopes of data analysis with ease.
Final remarks, questions, and farewells. Be sure to visit booth #1313 at ACMG 2024 to learn more and attend demos for an exclusive Golden Helix t-shirt.
Register Below
Enter your information below to register, and be sure to check your email for confirmation and to add to your calendar!